ã¡ãã£ã¢èšäº
ã€ãã«ã¡ã¯ãã³ã 誀ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
ããºãææ°ããŒã¯ 424
twitterã³ã¡ã³ã 388ä»¶äž 1ïœ100件
ã©ããªåŠæ¹è¬ã§ã飲ã¿ãããã°æ¯ã«ãªã
BBCèšäºã®çåœã¯ãšããããã€ãã«ã¡ã¯ãã³ãæªãããã«ååããŠãã®ã§ã¯ãšæãã
BBCèšäºã®çåœã¯ãšããããã€ãã«ã¡ã¯ãã³ãæªãããã«ååããŠãã®ã§ã¯ãšæãã
åŒç6åºã®å€§å³¶æŠãŸã ã€ãã«ã¡ã¯ãã³æšããªã®ãã
çŸå®ãåãå ¥ããŠã»ããã
çŸå®ãåãå ¥ããŠã»ããã
éå±ã¢ã¬ã«ã®ãŒãèæŒæ§è§åçãé¡ã®ã·ããèªç¥çãç³å°¿ç
ãè麻ç¹ã垯ç¶ç±ç¹ãé£èŽãèŠç¥çµåç
FFã®"äžèœè¬"ãçŸå®äžçã«æã£ãŠããããã ã
粟ç¥ç³»ã®ç æ°ã«ãŸã§å¹ããšã¯ããããã£ãã
FFã®"äžèœè¬"ãçŸå®äžçã«æã£ãŠããããã ã
粟ç¥ç³»ã®ç æ°ã«ãŸã§å¹ããšã¯ããããã£ãã
ã§ãããã€ãã«ã¡ã¯ãã³ãå©ããŠã¯ããªãã®ã§ãã
æé è«æãäžéšã¡ãã£ã¢ã§å®£äŒãã瀟äŒãèšåºã§æ°ã ã®åé¡ãåºãã®ã§ãå¥åº·ã害ããæãã®ããäžç¢ºããªæ å ±ã®çºä¿¡ããæ¹å€ããŠããã®ã§ãã
ã¬ã ãã·ãã«ã§ã¯ãããªã£ãŠãªãã
äžèšäºã¯ã»ãã®äžéšã§ãã
æé è«æãäžéšã¡ãã£ã¢ã§å®£äŒãã瀟äŒãèšåºã§æ°ã ã®åé¡ãåºãã®ã§ãå¥åº·ã害ããæãã®ããäžç¢ºããªæ å ±ã®çºä¿¡ããæ¹å€ããŠããã®ã§ãã
ã¬ã ãã·ãã«ã§ã¯ãããªã£ãŠãªãã
äžèšäºã¯ã»ãã®äžéšã§ãã
æ¢ã«ãåãã§ããããã¿ãŸããããæ¥æ¬èªã§ããããã®èšäº ãåèã«ãªããŸããéäžåœã§èº«è¿ãªãäžèœè¬ãã«å¯ŸããæåŸ
ããã£ããšããã«ããéœåãããïŒåŸã«ã§ã£ã¡ãããšå€æããïŒå¹ããšããããŒã¿ãçŸã㊠(bad science) 䜿ãããã®ããããã®åœã§ã¯äœ¿ãããŠå¹ããŠããã(ç¶
ã¯ã©ã¹ã¿ãŒå¯Ÿçã¯ç¡çç¶ææãããææçã§ã¯ç¡çã§ãããã¯ã©ã¹ã¿ãŒå¯Ÿçã«æã£ãããšãPCRæ€æ»ãæå¶ããã®ãé·æåã®åå ã§ãããã«ã¿æ ªã®æ¥éæžå°ã¯çºç¥¥å°ã®ã€ã³ãã§ã確èªãããŸãããçç±ã¯äžæã§ãã
ã€ãã«ã¡ã¯ãã³ã¯è«å€ã§ãã
ã€ãã«ã¡ã¯ãã³ã¯è«å€ã§ãã
æé ã£ãŠâŠãåãè
ã£ãŠãç§åŠè
ãªããããªãã®ã
æè¿å€ãã§ãããã
æè¿å€ãã§ãããã
10æ9æ¥ãšã¡ãã£ãšå€ãèšäºã ãã©ãããããå æžã€ãã«ã¡ã¯ãã³ã«å€¢ãèŠãã®ã¯ãããªãã
æ¥æ¬èªçãã©ãã
æ°åã³ãã ãŠã€ã«ã¹ææç æ¿ç
2021幎 è¡è°é¢ ç·éžæ
ð EBMç¡èŠ åè£
1 ð 2 ç«æ²æ°äž»å
山梚1åº ð æ±äº¬3åºð 3 æ¥æ¬ç¶æ°ã®äŒ
æ±äº¬5åº ð
2021幎 è¡è°é¢ ç·éžæ
ð EBMç¡èŠ åè£
1 ð 2 ç«æ²æ°äž»å
山梚1åº ð æ±äº¬3åºð 3 æ¥æ¬ç¶æ°ã®äŒ
æ±äº¬5åº ð
ã¡ãã£ãšååå·ã«å¯ã£ããšããç«æ²æ°äž»å
ã®æŸåãéžæã«ãŒã§ãã€ãã«ã¡ã¯ãã³ã®ç·æ¥äœ¿çšèš±å¯ãããšãé£åŒããŠããã©ãæ¬åœã«å匷ããŠãªãããªããã€ãã
銬çšã®å¯çè«è¬ãªããé ŒãŸããŠã飲ãŸã(_;)
ãå®ãçšåºŠã®å¹æãããªãã§ããã
ä»ãã£ãŠãæ²»éšã ã£ãŠã軜çè ãäžçç1ã§ãSpO95%以äžã®æ£è ã®éœæ§åå¿ãåºãªããªãæ¥æ°ãåªäœæ§ããããã ãã®ã»ãŒæå³ãªããã®ã ãã
ïŒSpO95%以äžãªããŠäžçç1ã§ããŸã 軜ãã»ãïŒ
ä»ãã£ãŠãæ²»éšã ã£ãŠã軜çè ãäžçç1ã§ãSpO95%以äžã®æ£è ã®éœæ§åå¿ãåºãªããªãæ¥æ°ãåªäœæ§ããããã ãã®ã»ãŒæå³ãªããã®ã ãã
ïŒSpO95%以äžãªããŠäžçç1ã§ããŸã 軜ãã»ãïŒ
ãã¡ãã®èšäºãèªãã§ãåèã«ðð»ââïž
ã€ãã«ã¡ã¯ãã³ã«ã€ããŠã¯ãå¹æã謳ãè«æã¯ãããŒã¿æ¹ç«ãªã©é ãææãããŠããŸã èªãããããã®ã¯æããŸããã
ãã«ãŒãšã€ã³ãã¯ãæ²»çè¬ãšããŠããŠã®æšå¥šãåãäžããŠããŸãã
ãããçŸç¶ã§ããã
ã€ãã«ã¡ã¯ãã³ã«ã€ããŠã¯ãå¹æã謳ãè«æã¯ãããŒã¿æ¹ç«ãªã©é ãææãããŠããŸã èªãããããã®ã¯æããŸããã
ãã«ãŒãšã€ã³ãã¯ãæ²»çè¬ãšããŠããŠã®æšå¥šãåãäžããŠããŸãã
ãããçŸç¶ã§ããã
åéãšèåãã€ãã«ã¡ã¯ãã³ã®éçåãèŽæ»äºé²ã¯è«ŠããŠããåéã®æ²»éšã§ã軜çè
åãã®ãã¿ãã³å€ã¬ãã«ã®å¹æã¯èŠããããšãããå ±åä»äžãã£ãŠããªãã ããããã
ç¥èå€æåæ¬ åŠããããã°ãã®å€±æçã¯100%ããäºå
šãŠééã£ãŠããããç²ãæ§ã§
ã
ã
ããã°ãã®æã£ãŠããåã¯ã¯ãã³çºè¡šã®ã¬ã»ãã¿ã¯äœã®æå³ããªããã€ãã«ã¡ã¯ãã³ã«æ°åã³ããå¹æããã£ããšããé©åãªæ€èšŒå ±åã¯1件ããªã
èŽæ»æ§ã®ããææçã§å¹æã®ãªãè¬ã®å¯Ÿç
§å®éšãè¡ãäºã¯å«ççã«åé¡ãããã
åã¯ã¯ãã³ã®ã¬ã»ãã¿ãæ
ãã€ããæ
匱ãšèšã
ããã«ãŒãšã€ã³ãã®ä¿å¥åœå±ã¯ãæ²»çã¬ã€ãã©ã€ã³ã®äžã§ã€ãã«ã¡ã¯ãã³ãæšå¥šããã®ããããã
ããã«ãŒãšã€ã³ãã®ä¿å¥åœå±ã¯ãæ²»çã¬ã€ãã©ã€ã³ã®äžã§ã€ãã«ã¡ã¯ãã³ãæšå¥šããã®ããããã
BBCæŸéã®æåãªèšäº
ïŒ2021幎10æ9æ¥ä»ãïŒ
ïŒ2021幎10æ9æ¥ä»ãïŒ
ããããBBCã®å ±é ãåºãŠãããªããããããæ²»éšåãã人ã¯åæ°ãããªã»ã»ã
ã¯ã¯ãã³æ¥çš®ããªãã§éœæ§ã«ãªã£ãæšãã®äººãã¡ãæ²»éšåãããã ãããã©ãèªåãªãæããŠç¡çã
ã¯ã¯ãã³æ¥çš®ããªãã§éœæ§ã«ãªã£ãæšãã®äººãã¡ãæ²»éšåãããã ãããã©ãèªåãªãæããŠç¡çã
ãæãããªæé ïŒãã€ããïŒã®å
åãããã¯ç 究ãç¡å¹ã«ããã»ã©ã®é倧ãªèª€ãããå«ãŸãªããã®ã¯ã1ã€ããªãã£ãã
ã€ãã«ã¡ã¯ãã³ã«é¢ãããããæµãã€ããã¯ã»ããšç©ã¿æ·±ãã
ã€ãã«ã¡ã¯ãã³ã«ããã¿ã€ããŠã人ããŸã ããã®ãã
ã©ã®ããã«COVID-19ã«äœçšããã®ãããŸã å ¬è¡šãããŠããªãã®ã«ã
ã©ã®ããã«COVID-19ã«äœçšããã®ãããŸã å ¬è¡šãããŠããªãã®ã«ã
æ
å ±ãå€ãããžãïŒå€§äžå€«ïŒéå»2ã¶æãããæ°çµ¶ããŠããïŒ
ã€ãã«ã¡ã¯ãã³
誀ã£ãç§åŠãçãã
æ°åãŠã€ã«ã¹ç¹å¹è¬
BBC 2021.10.9
ã€ãã«ã¡ã¯ãã³
é倧ãªå¯äœçšã«æèé害
ååŽçã3件ã®æ·»ææ¹èšæ瀺
10.12 æ¥åè¬æ¥
ã€ãã«ã¡ã¯ãã³åäººèŒžå ¥ã«èŠé
ç§åŠçæ ¹æ ãªã
10.17ç£çµæ°è
誀ã£ãç§åŠãçãã
æ°åãŠã€ã«ã¹ç¹å¹è¬
BBC 2021.10.9
ã€ãã«ã¡ã¯ãã³
é倧ãªå¯äœçšã«æèé害
ååŽçã3件ã®æ·»ææ¹èšæ瀺
10.12 æ¥åè¬æ¥
ã€ãã«ã¡ã¯ãã³åäººèŒžå ¥ã«èŠé
ç§åŠçæ ¹æ ãªã
10.17ç£çµæ°è
ãã®ãã¥ãŒã¹ãèŠãŠãŠåã¯âãâ掟ã奜ããããªè¬ã ãªããšããã£ãŠãã
詳ããâ
ç§ã®æçšããè¬é販ãµã€ãã§ããå šç¶ãéæšå¥šããšããŠãŸããªãçµå±ããŠãŒã¶ãŒãã¡ã®å€ãªã¬ãã¥ãŒãšæ¯æã§çãäžãã£ãŠããã®ãå®æ ã ã
ç§ã®æçšããè¬é販ãµã€ãã§ããå šç¶ãéæšå¥šããšããŠãŸããªãçµå±ããŠãŒã¶ãŒãã¡ã®å€ãªã¬ãã¥ãŒãšæ¯æã§çãäžãã£ãŠããã®ãå®æ ã ã
âœ
>COVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
>COVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
ãã€ãã«ã¡ã¯ãã³ãæ°åã³ãããžãã¯ã
åµè¬äŒç€ŸïŒã¡ã«ã¯ã»MSDïŒãèªããŠããŸããã
ã»åœé£ïŒWHOïŒ
ã»æ¥ïŒåççïŒ
ã»ç±³ïŒFDA,CDC,NIHïŒ
ã»æ¬§ïŒEMAïŒ
ã»è±ïŒUK-CTAPïŒ
âŠçã§æªèšŒæã»èšŒæ倱æã§ãã
èªãã§ãã ããã
â
åµè¬äŒç€ŸïŒã¡ã«ã¯ã»MSDïŒãèªããŠããŸããã
ã»åœé£ïŒWHOïŒ
ã»æ¥ïŒåççïŒ
ã»ç±³ïŒFDA,CDC,NIHïŒ
ã»æ¬§ïŒEMAïŒ
ã»è±ïŒUK-CTAPïŒ
âŠçã§æªèšŒæã»èšŒæ倱æã§ãã
èªãã§ãã ããã
â
>CBNãã¥ãŒã¹ã®èšäº
â
æé ãå€ãã蚌æãšèªå¯ã«ãªã£ãŠããŸããã
2021/10/09
âœ
>COVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€
â
æé ãå€ãã蚌æãšèªå¯ã«ãªã£ãŠããŸããã
2021/10/09
âœ
>COVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€
å¯çè«ãé§é€ããè¬ã§æ°åã³ããã«å¯ŸããããŒã¿ãå°ãªãããŸãæ¹ç«ãå€ãäºããç§åŠçãªæ ¹æ ã«ä¹ãã
æ ç» ã®ããã«èžãããŠãã人ãåºãŠãããã ãã
æ ç» ã®ããã«èžãããŠãã人ãåºãŠãããã ãã
âœ
>COVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
>COVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
ã€ã³ãã¯ã€ãã«ã¡ã¯ãã³æšé²ãåæ¢ããŠãããå¹æç¡ãã£ãäºãæ¿åºã«ãç解ããããã ãããªãä»æŽã€ãã«ã¡ã¯ãã³ã®è©±ã§ããïŒ
By Rachel Schraer & Jack Goodman
BBC Reality Check
BBC Reality Check
â£
>æ»è ã¯äžæ
â
äŸ:
ã»ã¯ã¯ãã³æ¥çš®âèŽæ»çäžæãªã
ã»ã€ãã«ã¡ã¯ãã³âæ¹å確çäžæãªã
ã»æ°åã³ããâåŸæ¥æ ªã§å¹Žéœ¢ååžãæãããšèŽæ»ç1.9%
âœCOVID-19æ»äº¡çã®éãã¯å¹Žéœ¢ååžã®åœ±é¿ã倧
âœã€ãã«ã¡ã¯ãã³
>æ»è ã¯äžæ
â
äŸ:
ã»ã¯ã¯ãã³æ¥çš®âèŽæ»çäžæãªã
ã»ã€ãã«ã¡ã¯ãã³âæ¹å確çäžæãªã
ã»æ°åã³ããâåŸæ¥æ ªã§å¹Žéœ¢ååžãæãããšèŽæ»ç1.9%
âœCOVID-19æ»äº¡çã®éãã¯å¹Žéœ¢ååžã®åœ±é¿ã倧
âœã€ãã«ã¡ã¯ãã³
æ¥æ¬åœå
ã§ã®å ±éããŸãç¡ãã®ã¯æ°ã®ããïŒ
æ¯èŠªãåã¯ã¯ãã³æŽŸé°è¬è«è
ã«ã€ãã«ã¡ã¯ãã³è²°ã£ãŠåž°ã£ãŠãããã ãã©ããžã§ãããŠãã
BBCã®èšäºã®ç¿»èš³ããããŸããã
è±BBCãã³ããç¹å¹è¬ã€ãã«ã¡ã¯ãã³ãå·§åŠã«åŠå®
äžçã§èµ·ããäºè±¡ã®å€§åã玹ä»ããŠãäžéšã®åäŸã§æå¹æ§ãšå®å šæ§ãåŠå®ããäžå¯§ãªèšè¿°
ã ããã€ã³ãåŒè·å£«äŒãWHOã蚎ããã€ã³ããã€ãã«ã¡ã¯ãã³ã§ææçµæ¯ãããäºå®ã¯é ãã
ã€ã³ãã§èµ·ããäºå®ã¯åŠå®ã§ããªãçå®ã
â
äžçã§èµ·ããäºè±¡ã®å€§åã玹ä»ããŠãäžéšã®åäŸã§æå¹æ§ãšå®å šæ§ãåŠå®ããäžå¯§ãªèšè¿°
ã ããã€ã³ãåŒè·å£«äŒãWHOã蚎ããã€ã³ããã€ãã«ã¡ã¯ãã³ã§ææçµæ¯ãããäºå®ã¯é ãã
ã€ã³ãã§èµ·ããäºå®ã¯åŠå®ã§ããªãçå®ã
â
âãã€ãã«ã¡ã¯ãã³ãã¯æ°åã³ãããŠã€ã«ã¹ææçCOVID-19ã®ãå¥è·¡ã®ãæ²»çè¬ãšåŒã°ããã¯ã¯ãã³å察掟ã«æ¯æãããŠããã»ããäžéšã®åœã®ä¿å¥åœå±ã䜿çšãæšå¥šããŠãããâ
âããããæ ¹æ ãšããŠããå€ãã®éèŠãªç 究ã«ã¯ãæ·±å»ãªèª€ããããããšãæããã«ãªã£ãŠãããâ
âããããæ ¹æ ãšããŠããå€ãã®éèŠãªç 究ã«ã¯ãæ·±å»ãªèª€ããããããšãæããã«ãªã£ãŠãããâ
ã€ãã«ã¡ã¯ãã³ã®å ±éã§ãã
âã€ãã«ã¡ã¯ãã³
ã圌女ã¯æªåãå§ãããšãé©åãªæ€æ»ãæ²»çãåãããã€ãã«ã¡ã¯ãã³ã§èªåãæ²»çããã
ã(äžç¥)ãé¡ãã ããç·æ¥æ²»ç宀ã«é£ããŠè¡ã£ãŠã»ãããšé Œãã ã
ãæåã圌女ãã¡ã¯æ¶æ¥µçã ã£ãããç§ã¯è¡ãããã«èª¬åŸãããæ°æéåŸã圌女ã¯æ¯ãåŒãåã£ãã
ã圌女ã¯æªåãå§ãããšãé©åãªæ€æ»ãæ²»çãåãããã€ãã«ã¡ã¯ãã³ã§èªåãæ²»çããã
ã(äžç¥)ãé¡ãã ããç·æ¥æ²»ç宀ã«é£ããŠè¡ã£ãŠã»ãããšé Œãã ã
ãæåã圌女ãã¡ã¯æ¶æ¥µçã ã£ãããç§ã¯è¡ãããã«èª¬åŸãããæ°æéåŸã圌女ã¯æ¯ãåŒãåã£ãã
ãã¡ã®ãããã飲ãã§ããªâŠ
ã€ãã«ã¡ã¯ãã³ã®æ²»çå¹æã«ã€ããŠèšŒèšããåç»ã¯ãããã°ããã¯ã«ããæ€é²ã§ã«ãããããã
ã§ã¯ææ¬éŠããã®åæãæå¹æ§ãäŒããå»åž«ã®èšèãYoutubeã§ã¯äºãã«ããããŠæŸéã
ã¯å®å šçãåç©çšãšãåäººèŒžå ¥ãææããå»åž«ã®èšèãã
äœãæ£ããïŒð©
ã§ã¯ææ¬éŠããã®åæãæå¹æ§ãäŒããå»åž«ã®èšèãYoutubeã§ã¯äºãã«ããããŠæŸéã
ã¯å®å šçãåç©çšãšãåäººèŒžå ¥ãææããå»åž«ã®èšèãã
äœãæ£ããïŒð©
æ¥æ¬èªçã貌ã£ãŠãããŸãã
ã¯ïŒã€ãã«ã¡ã¯ãã³ã¯å¯äœçšãçµæ§é節ãªãã®ãå€ããã ãã©ïœå€§äžå€«ãããª...ã³ããã«å¹ããªããŠã»ãŒãããããŠ...
ãªããåãµã€ãã®æžã蟌ã¿èŠãŠããŸã ã€ãã«ã¡ã¯ãã³ä¿¡ããŠã人ãããããšã«é©ããããã¯åç©ã§ã®è©±ã人éçšã¯å¯äœçšãªãããšã
èªèº«ãä¿¡ããã®ã¯åæã«ãããšèšããããã人ã«å§ããã®ã¯ãã¡ã ãã
æ¿èªæžã¿ã®ã¯ã¯ãã³ãæã¿æªæ¿èªã®å®èšŒå®ãã§ãªãè¬ãä¿¡ããæ°æã¡ã床ãé£ã
èªèº«ãä¿¡ããã®ã¯åæã«ãããšèšããããã人ã«å§ããã®ã¯ãã¡ã ãã
æ¿èªæžã¿ã®ã¯ã¯ãã³ãæã¿æªæ¿èªã®å®èšŒå®ãã§ãªãè¬ãä¿¡ããæ°æã¡ã床ãé£ã
誀ã£ãç§åŠãçãã ç¹å¹è¬
ã€ãã«ã¡ã¯ãã³ã¯æ°åã³ããææçã®ãå¥è·¡ã®ãæ²»çè¬ãšåŒã°ããã¯ã¯ãã³å察掟ã«æ¯æãããŠããã»ããäžéšã®åœã®ä¿å¥åœå±ã䜿çšãæšå¥šããŠããããæ·±å»ãªèª€ããããããšãæããã«ãªã£ãŠããã
ãããªæã ããããæ£ããå€æã
ã€ãã«ã¡ã¯ãã³ã¯æ°åã³ããææçã®ãå¥è·¡ã®ãæ²»çè¬ãšåŒã°ããã¯ã¯ãã³å察掟ã«æ¯æãããŠããã»ããäžéšã®åœã®ä¿å¥åœå±ã䜿çšãæšå¥šããŠããããæ·±å»ãªèª€ããããããšãæããã«ãªã£ãŠããã
ãããªæã ããããæ£ããå€æã
çµå±ã€ãã«ã¡ã¯ãã³ã¯è«æã«äžåããã£ãŠå®¢èŠ³çãªå¹æèªããããªããã ããïŒ
ã€ãã«ã¡ã¯ãã³ãé倧ãªå¯äœçšã«
æèé害
ååŽçã3件ã®æ·»ææ¹èšæ瀺
2021.10.12æ¥åè¬æ¥
Desperation, misinformation
how the ivermectin craze spread across
The Guardian
誀ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ç¹å¹è¬ BBC
æèé害
ååŽçã3件ã®æ·»ææ¹èšæ瀺
2021.10.12æ¥åè¬æ¥
Desperation, misinformation
how the ivermectin craze spread across
The Guardian
誀ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ç¹å¹è¬ BBC
ã¢ãã¬ã³åŸ
æè«ã¯äœåŠïŒ
åœãšéã«çŽçµããããã
çžåœæ éã«ããŠããããªããšã
çžåœæ éã«ããŠããããªããšã
ã€ãã«ã¡ã¯ãã³ãæ°åã³ããã«æå¹ã§ãããšããæ²»éšããŒã¿ã¯ãããŸããã
é·å°Ÿå»åž«ã¯ããã€ãã³ã°ã§ã
ãåãèšã£ãŠãããšãééã£ãŠãããåã¯è²¬ä»»åã£ãŠå»è èŸããŸãã
ãšèšã£ãŠããã©ãèŠããŠãŸããïŒ
ãŸããééã£ãŠãããšã¯èªããªãã§ããããã©ã
é·å°Ÿå»åž«ã¯ããã€ãã³ã°ã§ã
ãåãèšã£ãŠãããšãééã£ãŠãããåã¯è²¬ä»»åã£ãŠå»è èŸããŸãã
ãšèšã£ãŠããã©ãèŠããŠãŸããïŒ
ãŸããééã£ãŠãããšã¯èªããªãã§ããããã©ã
BBCãã€ãã«ã¡ã¯ãã³ãåŠå®
Dr.John Campbell
BBCã¯åœéçã«éåžžã«é«ãè©äŸ¡ãåŸãŠããŸããè±åœæŸéåäŒã¯ããã€ãŠã¯éåžžã«åªããçµç¹ã§ãããæµ·å€ã«ãã人ã¯ãã¡ãããã¢ã¡ãªã«ã«ãã人ã§ããBBCã®çŽ æŽããããç¥ããªã人ã¯ããªãã§ããããæã¯æ¬åœã«è¯ãã£ããã§ããã©ãã
Dr.John Campbell
BBCã¯åœéçã«éåžžã«é«ãè©äŸ¡ãåŸãŠããŸããè±åœæŸéåäŒã¯ããã€ãŠã¯éåžžã«åªããçµç¹ã§ãããæµ·å€ã«ãã人ã¯ãã¡ãããã¢ã¡ãªã«ã«ãã人ã§ããBBCã®çŽ æŽããããç¥ããªã人ã¯ããªãã§ããããæã¯æ¬åœã«è¯ãã£ããã§ããã©ãã
ç§ã®çŸ©ç¶ã¯é·å¹Ž 枡蟺åšããã«æ祚ããŠããŸããããèªã¿é ããªãã®ã§ããããâŠ
æèŠã®éãåœæ°ã®å£°ãèããŠäžããã
æèŠã®éãåœæ°ã®å£°ãèããŠäžããã
æ€èšŒã®çµæãã€ãã«ã¡ã¯ãã³ãCOVID-19ã«å¯ŸããŠå¹æããããšãã蚌æ ã¯ãŸã£ãããªãã£ããããã§ãããã®èšäºã®ã»ããæé ã ãšæã人ãããã®ã ãããªã
BBCã®è§£èª¬èšäºã§ãã
ã€ãã«ã¡ã¯ãã³ã ïŒïŒïŒç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ðã
åºåŠäžæãªåå¹ä»ãåç»ã¯ãã芳ãã®ã«ãããããã®ã¹ã«ãŒããã®ãªã
ïŒåïŒã€ãã«ãã®äººãŸã§æ¯çã«ãä»®ã«ããå
Œ
±æŸéãããããªãã¡ããã¡ããªãããæµããŠããã®ã ãããïŒåŠåš ãšåºç£ãå°éã®å»åž«ãã¹ã»ããŒãªãŒå士ã¯...
ã€ãã«ã¡ã¯ãã³ã«ã€ããŠã¯å€§æå士ãå¹æãåŠå®ããŠããªãããããŸã§ãããããŸãªåŠå®ã®é£çºã¯ã¡ã«ã¯ã®æ°è¬ãã¯ã¯ãã³ããžãã¹ã®æè·ã®ããã«ãªãããŠããæ§çžãããä¿¡çšã§ããªãã圌ãã«ãšãã°äŸ¡æ Œã®å®ãã€ãã«ã¡ã¯ãã³ãå¹æããããšäžéœåã ãã ãããããŸã§å©ãã®ã ããã
>COVID-19ã®ãå¥è·¡ã®ãæ²»çè¬ãšåŒã°ããã¯ã¯ãã³å察掟ã«æ¯æãããŠããã»ããäžéšã®åœã®ä¿å¥åœå±ã䜿çšãæšå¥šâŠãããâŠãã®è¬ãæšé²ããŠãã人ã
ãæ ¹æ ãšããŠããå€ãã®éèŠãªç 究ã«ã¯ãæ·±å»ãªèª€ãããã
ãããäžžå·å
äºèŒªçžãšèšãåœäŒè°å¡ãå»çããæµããªãã§ããåœã«ããããã蚌跡ãè¯ãçºãŸã£ãèšäºïŒ
ããã€ãã¡ã®éžæåºã§èªæ°å 以å€ã«æ祚ãããæã«æåãªæ祚å ã®äžã€ãªãã ãããå±ããæ祚å ã«ã§ããªã
åŸã¯å ±ç£å ãïŒããããå ¥ããããªããåè£è åºããŠãããããã
ããã€ãã¡ã®éžæåºã§èªæ°å 以å€ã«æ祚ãããæã«æåãªæ祚å ã®äžã€ãªãã ãããå±ããæ祚å ã«ã§ããªã
åŸã¯å ±ç£å ãïŒããããå ¥ããããªããåè£è åºããŠãããããã
å»åŠçæ ¹æ ã極ããŠè匱ã§ãã
çŸå®³ãã£ãŠâŠãšãŸã§ã¯èšããªãã«ããŠããã€ãã«ã¡ã¯ãã³ãæäžãããšããã§æ£è ããã«ã¯äžå©ããããŸããã
åœæ¿æ¿å ãšããŠã®ä¿¡é Œæ§ãèªãèœãšããŠã©ãããã®ã§ãããæ å ±çºä¿¡ããããªãããŸãšããªæ å ±æºã粟æ»ããŠãã ããã
çŸå®³ãã£ãŠâŠãšãŸã§ã¯èšããªãã«ããŠããã€ãã«ã¡ã¯ãã³ãæäžãããšããã§æ£è ããã«ã¯äžå©ããããŸããã
åœæ¿æ¿å ãšããŠã®ä¿¡é Œæ§ãèªãèœãšããŠã©ãããã®ã§ãããæ å ±çºä¿¡ããããªãããŸãšããªæ å ±æºã粟æ»ããŠãã ããã
誀ã£ãç§åŠã£ãŠãªããšæããã©ãªãç§åŠãšã¯èšãã
å¹ããªããç¹å¹è¬ãã£ãŠãªãã ããïŒ
å¯åå¿ã ããã®ã¯ã¯ãã³ã¯ãã¡ãæšãããŠããã®ã«ð©
ãªããããŸã§ã€ãã«ã¡ã¯ãã³ãå©ãã®ã ããïŒð€
ãªããããŸã§ã€ãã«ã¡ã¯ãã³ãå©ãã®ã ããïŒð€
ãæãããªæé ïŒãã€ããïŒã®å
åãããã¯ç 究ãç¡å¹ã«ããã»ã©ã®é倧ãªèª€ãããå«ãŸãªããã®ã¯ã1ã€ããªãã£ãã
ãã®è¡šçŸãåã¯ã¯ã®è³ã¿ãã§ã¯åŠçã§ããªããããããªãã
ãã®è¡šçŸãåã¯ã¯ã®è³ã¿ãã§ã¯åŠçã§ããªããããããªãã
ã ãããã
é©éãªãå®å
šãªã®ã§ãããäœã®ããã«ã€ãã«ã¡ã¯ãã³ã¯å¿
èŠã ãšãèãã§ããïŒ
念ã®ããæµ·å€ã§ã®å ±éã貌ãä»ããšããŸãã
ïŒãããå šãŠãšã¯èšããŸãããã俯ç°çã«ã¿ãŠå€æããŠãã ããïŒ
ïŒãããå šãŠãšã¯èšããŸãããã俯ç°çã«ã¿ãŠå€æããŠãã ããïŒ
ã€ãã«ã¡ã¯ãã³
誀ã£ãç§åŠãçãã
æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
誀ã£ãç§åŠãçãã
æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
ãããã€ãã§ã«ãã®èšäºãåºãç¥ãããã»ãããããã BBCïŒ
ãããç§åŠçã«ç«èšŒããŠãä¿¡è
éã¯ãèªåéã®ä¿¡ããæ
å ±ããåãä»ããªãããèªç¶ã®æçã«é ãããããªã
Memo
ãBBCã®åæã§ã¯ãCOVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãã
ãBBCã®åæã§ã¯ãCOVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãã
ãšããããã§ã€ãã«ã¡ã¯ãã³ã«ã€ããŠã¯ããã§ããŸãïŒ
å¹ãã£ãŠèšãããããªãã¡ãããšããŒã¿ãã£ãšãã§ããçŸå®ãåæ ããããŒã¿ãããã
å¹ãã£ãŠèšãããããªãã¡ãããšããŒã¿ãã£ãšãã§ããçŸå®ãåæ ããããŒã¿ãããã
ãã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
ããããç¥ç¬ã®æ£è ããã«è¿ããŠãããŸããããïŒ
ããããç¥ç¬ã®æ£è ããã«è¿ããŠãããŸããããïŒ
ã³ã¡ã³ãæ¬ãªãåŠå®ããã»ã©æªããŸããŠãã
åé¡ãããããªããããã®åèš³ã ãšè¬ãã®ãã®ã誀ã£ãç§åŠã«ãã£ãŠãããã®ããã«èªããæ°ãããã
æ¥æ¬åž°åœãèããŠãã人ã®çç±ã«ãã€ãã«ã¡ã¯ãã³ãè²·ããããã£ãŠããã®ãTLã«æµããŠæ¥ãŠããªãã ããªãããšæãã
ããããã°ã€ãã«ã¡ã¯ãã³éšå
ã
ã
ïŒã€ãã«ã¡ã¯ãã³ã®è£œé ã¡ãŒã«ãŒã®1ã€ãã¡ã«ã¯ã¯2æããCOVID-19ã«å¯Ÿããæ²»çå¹æã®å¯èœæ§ã瀺ãç§åŠçæ ¹æ ã¯äœããªãããšèª¬æããã
ãŸããããçµè«ã§ãããã
ãŸããããçµè«ã§ãããã
ãBBCã®åæã§ã¯ãCOVID-19æ²»çè¬ãšããŠã®ã€ãã«ã¡ã¯ãã³ã®äœ¿çšã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããšãæããã«ãªã£ãããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªããã
ã°ããªã®ïŒ
BBCã¯çžå€ãããã ãªïœðŠ
è±PRINCIPLEã®æ²»éšçµæããããæ矀ãªå 容ã ã£ããã©ãããã€ãããªãã ã
ãšããããèªè ã³ã¡ã³ãæ¬ãåãã£ãŠããæ¹ã ã°ããã§ãããåããð€
è±PRINCIPLEã®æ²»éšçµæããããæ矀ãªå 容ã ã£ããã©ãããã€ãããªãã ã
ãšããããèªè ã³ã¡ã³ãæ¬ãåãã£ãŠããæ¹ã ã°ããã§ãããåããð€
ã³ããçŠãç«æ²æ°äž»å
äžã§ãã£ãããã€ãã«ã¡ã¯ãã³ãããã€ãã«ã¡ã¯ã¯ãã³ããšç§°ãããŠæäžãããŠããšæããšææãããªã
ã·ã§ã«ããªãã¯å士ãã€ãã«ã¡ã¯ãã³ãCOVID-19ã«ããæ»ãé²ãããšã瀺ããããšäž»åŒµããèšåºè©Šéšã®äžã«ãæãããªæé ã®å
åãããã¯ç 究ãç¡å¹ã«ããã»ã©ã®é倧ãªèª€ãããå«ãŸãªããã®ã¯ã1ã€ããªãã£ãããšè¿°ã¹ã
ã€ãã«ã¡ã¯ãã³èª€ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
ã€ãã«ã¡ã¯ãã³èª€ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
ãã®èšäºãèªãã§ã¿ãã¹ãã ãããŒã¿ã«ãã¥ãŒã¹ã¯ãŒã«ããããä¿¡çšã§ããã ããã
æ³åããŠãããããã£ãšé
·ãw
ã»ãŒã
çžå€ãããã®åŠå®èšäºãäœæ
ãã®ã¿ã€ãã³ã°ïŒãð€£
ã§ãçµå±ã©ãŒãªã®ïŒ
ã€ãã«ã¡ã¯ãã³ã®æ¯æè
ãåã¯ã¯ãã³ãé°è¬è«ãšçµã³ã€ããŠããã®ã¯æ¥æ¬ã«éããåºãèŠãããçŸè±¡ãªãã§ããã
ãŸãããããããªãã§ããããã©ã
ãŸãããããããªãã§ããããã©ã
ã€ãã«ã¡ã¯ãã³ã¯ããã ã®è«äžãã ã(^_^;)
çŸæ®µéã§æ°åã³ããã«ææããŠæ²»çã«æå¹ãªã®ã¯ãæäœã«ã¯ãã«çæ³ã ãã
æ°ãã«æ¿èªãããå§ããçµå£ã¿ã€ãã®æ²»çè¬ãæå ¥ããããšãå°ãæ²»çã®å¹ ã¯åºãããšã¯æãã
çŸæ®µéã§æ°åã³ããã«ææããŠæ²»çã«æå¹ãªã®ã¯ãæäœã«ã¯ãã«çæ³ã ãã
æ°ãã«æ¿èªãããå§ããçµå£ã¿ã€ãã®æ²»çè¬ãæå ¥ããããšãå°ãæ²»çã®å¹ ã¯åºãããšã¯æãã
åã¯ã¯ãã³è³ãæŸå°è³ã®äººã以å€ãšãŸã å€ãã®ããã
ãã¯ã¯ãã³ã¯ã¯å©æš©ïŒã€ãã«ã¡ã¯ãã³ãå©ããéïŒããšãèšã£ãŠãé£äžããããã€ãã«ã¡ã¯ãã³å©æš©ã®çæ£ãæ
ãã ããå±ã ã£ãèš³ã ã
ããããã°ç«æ²æ°äž»å ãã€ãã«ã¡ã¯ãã³æšé²æŽŸã ã£ããªâŠã
ããããã°ç«æ²æ°äž»å ãã€ãã«ã¡ã¯ãã³æšé²æŽŸã ã£ããªâŠã
äœæ
çµè«ãæ¥ãïŒæªç¥ã®ãŠã€ã«ã¹ãªãã ããä»ããçµæãåºããã®ã§ã¯ç¡ããå»çã®é°è¬èª¬ãè延ãããã ãã ãäœæ
BBCïŒãªãŒãããŠããã€ãããïŒ
ãã®BBCã®èšäºã«å¯ŸããŠã€ããã€ãã³ã¡ã¯ãã¡ãã«ãªããŸãã
å㞠次ãž
çŸç¶ãå¹ãã人ãããã£ãŠèªèããã§ããªãã
å°å ã®éžæã§ã€ãã«ã¡ã¯ãã³ãçã«âŠã£ãŠãã£ãŠãã¿ããã ãã
ãããæ²»çè¬æ±ãã§äºé²å¹æãªããŠèŠã€ãããªãã£ãããã